Kura Oncology Inc (KURA)

Dec 30, 2024

Kura Oncology (NASDAQ:KURA) Hits New 12-Month LowHere's Why - MarketBeat

Dec 30, 2024

Dec 30, 2024

Kura Crashes 37% After $1.53 Billion Deal Slams The Door On A Takeover - MSN

Dec 30, 2024

Dec 30, 2024

Kura Oncology, Inc. (NASDAQ:KURA) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat

Dec 30, 2024

Dec 30, 2024

Kura Oncology, Inc. (NASDAQ:KURA) Given Average Recommendation of “Buy” by Analysts - Defense World

Dec 30, 2024

Dec 28, 2024

Objective long/short (KURA) Report - Stock Traders Daily

Dec 28, 2024

Dec 26, 2024

Kura Oncology (NASDAQ:KURA) Sets New 12-Month Low – Here’s What Happened - Defense World

Dec 26, 2024

Dec 24, 2024

Kura Oncology's Stock Sinks To US$8.94, But Insiders Sold Even Lower - Simply Wall St

Dec 24, 2024

Dec 24, 2024

Kura Oncology (NASDAQ:KURA) Reaches New 12-Month LowWhat's Next? - MarketBeat

Dec 24, 2024

Dec 23, 2024

Kura Oncology stock hits 52-week low at $8.83 amid market challenges - Investing.com Australia

Dec 23, 2024

Dec 20, 2024

Kura Oncology expands stock option plan - Investing.com

Dec 20, 2024

Dec 20, 2024

Kura Oncology expands stock option plan By Investing.com - Investing.com UK

Dec 20, 2024

Dec 18, 2024

Kura Oncology (NASDAQ:KURA) Reaches New 52-Week LowWhat's Next? - MarketBeat

Dec 18, 2024

Dec 18, 2024

Kura Oncology Presents Deep Value At Today's Prices (Rating Upgrade) (NASDAQ:KURA) - Seeking Alpha

Dec 18, 2024

Dec 18, 2024

(KURA) Proactive Strategies - Stock Traders Daily

Dec 18, 2024

Dec 15, 2024

Kura Oncology's SWOT analysis: ziftomenib's promise buoys stock outlook By Investing.com - Investing.com UK

Dec 15, 2024

Dec 14, 2024

Kura Oncology's SWOT analysis: ziftomenib's promise drives stock outlook By Investing.com - Investing.com South Africa

Dec 14, 2024

Dec 14, 2024

Kura Oncology's SWOT analysis: ziftomenib's promise drives stock outlook - Investing.com India

Dec 14, 2024

Dec 13, 2024

Kura Oncology's SWOT analysis: ziftomenib's potential reshapes cancer stock landscape - Investing.com Canada

Dec 13, 2024

Dec 10, 2024

Kura Oncology’s (KURA) Overweight Rating Reaffirmed at Cantor Fitzgerald - Defense World

Dec 10, 2024

Dec 09, 2024

Kura Oncology, Inc. (NASDAQ:KURA) Q3 2024 Earnings Call Transcript - MSN

Dec 09, 2024

Dec 09, 2024

Kura Oncology and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting - The Manila Times

Dec 09, 2024

Dec 09, 2024

Kura Oncology and Kyowa Kirin Report Positive Combination Data for Ziftomenib At American Society of Hematology Annual Meeting - Marketscreener.com

Dec 09, 2024

Dec 06, 2024

RA CAPITAL MANAGEMENT, L.P. Acquires Significant Stake in Kura Oncology Inc - GuruFocus.com

Dec 06, 2024

Dec 05, 2024

Purple Biotech Secures $2.8 Million for Oncology Advancements - MSN

Dec 05, 2024

Dec 05, 2024

Kura Oncology, Inc. (NASDAQ:KURA) Given Consensus Rating of "Buy" by Analysts - MarketBeat

Dec 05, 2024

Dec 04, 2024

Why Is Kura Oncology, Inc. (KURA) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds? - Insider Monkey

Dec 04, 2024

Dec 03, 2024

Kura Oncology Inc (NASDAQ: KURA) Gains 1.45% In Early Trade; What Lies Ahead? - Stocks Register

Dec 03, 2024

Dec 03, 2024

Kura Oncology Inks $1.16B Partnership with Kyowa Kirin - San Diego Business Journal

Dec 03, 2024

Dec 02, 2024

Kura Oncology to Host Virtual Investor Event on December 9, 2024 - The Manila Times

Dec 02, 2024

Dec 02, 2024

Kura Oncology to Host Investor Event on Ziftomenib Clinical Trial Data from ASH Meeting | KURA Stock News - StockTitan

Dec 02, 2024

Nov 29, 2024

ImmuneOnco Raises Funds for Cancer Research - MSN

Nov 29, 2024

Nov 27, 2024

Kura Oncology price target raised to $37 from $32 at H.C. Wainwright - MSN

Nov 27, 2024

Nov 27, 2024

Kura Oncology’s Collaboration with Kyowa Kirin - Global Legal Chronicle

Nov 27, 2024

Nov 26, 2024

How to Take Advantage of moves in (KURA) - Stock Traders Daily

Nov 26, 2024

Nov 26, 2024

Kura Oncology's SWOT analysis: precision cancer drug stock faces pivotal year - Investing.com India

Nov 26, 2024

Nov 26, 2024

Kura, Kyowa Kirin to co-develop ziftomenib in $1.49B deal - BioWorld Online

Nov 26, 2024

Nov 25, 2024

Kura Oncology to Participate in JMP Securities Hematology and Oncology Summit - The Manila Times

Nov 25, 2024

Nov 25, 2024

Kura Oncology CEO to Present at JMP Securities Hematology & Oncology Summit | KURA Stock News - StockTitan

Nov 25, 2024

Nov 25, 2024

Cantor Fitzgerald Reaffirms Overweight Rating for Kura Oncology (NASDAQ:KURA) - Defense World

Nov 25, 2024

Nov 25, 2024

Kura Oncology (NASDAQ:KURA) Given Buy Rating at TD Cowen - Defense World

Nov 25, 2024

Nov 25, 2024

FY2025 EPS Estimate for Kura Oncology Raised by Analyst - Defense World

Nov 25, 2024

Nov 25, 2024

Jefferies Financial Group Issues Pessimistic Forecast for Kura Oncology (NASDAQ:KURA) Stock Price - Defense World

Nov 25, 2024

Nov 25, 2024

Kura Oncology (NASDAQ:KURA) Stock Price Expected to Rise, HC Wainwright Analyst Says - Defense World

Nov 25, 2024

Nov 25, 2024

Brokers Offer Predictions for Kura Oncology FY2025 Earnings - MarketBeat

Nov 25, 2024

Nov 25, 2024

Leerink Partnrs Predicts Stronger Earnings for Kura Oncology - MarketBeat

Nov 25, 2024

Nov 24, 2024

Bank of America Issues Pessimistic Forecast for Kura Oncology (NASDAQ:KURA) Stock Price - Defense World

Nov 24, 2024

Nov 23, 2024

Kura Oncology partners Kyowa Kirin to advance AML treatment - MSN

Nov 23, 2024

Nov 23, 2024

Kura Oncology (NASDAQ:KURA) Sees Large Volume Increase on Analyst Upgrade - MarketBeat

Nov 23, 2024

Nov 23, 2024

Kura Oncology, Inc. (KURA): Among the Most Promising Cancer Stocks According to Hedge Funds - Insider Monkey

Nov 23, 2024

Nov 23, 2024

Kura Oncology & Kyowa Kirin ink billion dollar deal to develop and commercialise Ziftomenib for acute leukemia treatment - BSA bureau

Nov 23, 2024